In this post, our Roundup lawyers will give you:
Bard PowerPort lawsuits allege that defects in implanted port catheters can cause fractures, migration, blood clots, infections, embolisms, and other serious complications. Thousands of product liability lawsuits are now pending against Bard and its parent company, Becton Dickinson, in a federal multidistrict litigation in Arizona. After a long slog, these cases are now moving forward.
The first bellwether trial ended with a partial defense verdict and a deadlocked jury on the central design defect claim. The most recent trial, Divelbliss v. C.R. Bard, led to a $40 million verdict. It involved an alleged fracture of a silicone Groshong catheter. Five bellwether trials are now expected to run through February 2027. Our lawyers remain bullish on well-documented fracture, migration, and embolization cases.
This page provides the latest Bard PowerPort lawsuit updates, projected settlement amounts, and information about who may qualify to file a claim.
Our lawyers are handling Similac and Enfamil infant formula lawsuits for families whose premature babies suffered or died from necrotizing enterocolitis (NEC) after taking one of these formulas. Our law firm is reviewing NEC lawsuits in all 50 states.
Medical research links cow milk-based infant formulas such as Similac and Enfamil to a dangerous neonatal medical condition known as necrotizing enterocolitis. These newborn NEC formula lawsuits make many allegations. At their core, they allege that the makers of these formulas knew of the risk of NEC and did nothing to warn families or give them a choice.
If your premature baby was diagnosed with NEC after being given Similac or Enfamil formula, you may be able to file an NEC baby formula lawsuit against the formula companies and receive financial compensation for the harm that was done to your child.
Our lawyers handle Paraquat lawsuits in all 50 states. This page provides the latest news and updates on Paraquat lawsuits in both state and federal courts. We also give our perspective on where this litigation is heading and provide projected settlement payouts for a viable Paraquat lawsuit. Continue reading
We have also recently reopened the comments below to answer any questions you may have or simply give you a chance to share your thoughts.
This page is for women considering filing a Depo-Provera lawsuit. Our lawyers provide the latest updates, explain the litigation and settlement process, and offer our assessment of potential Depo-Provera settlement amounts.
Scientific research has found a strong association between prolonged use of injectable medroxyprogesterone acetate, the active drug in Depo-Provera, and intracranial meningioma. Women who received Depo-Provera injections and were later diagnosed with a meningioma are filing lawsuits alleging that Pfizer and related companies failed to provide an adequate warning.
Dupixent lawsuits are now moving forward in federal court for patients who allege the drug caused, accelerated, or unmasked cutaneous T-cell lymphoma and related T-cell lymphomas.
On June 4, 2026, the Judicial Panel on Multidistrict Litigation centralized the federal Dupixent cases in MDL No. 3180, In re: Dupixent (Dupilumab) Products Liability Litigation, in the District of New Jersey before Judge Zahid N. Quraishi.
Dupixent, also known as dupilumab, is a biologic medication used to treat atopic dermatitis, asthma, COPD, and a host of other inflammatory conditions. For many patients, Dupixent has provided real relief where other treatments failed. But for some patients, the story has been very different and not one they could have expected.
Currently, thousands of hernia mesh lawsuits are pending in courts across the country. Our hernia mesh lawyers are handling these cases in all 50 states. This page:
Between 2013 and 2024, contaminated Olympus duodenoscopes infected hundreds of patients at hospitals across the United States. At least 35 people died.
What happened? These awful infections were caused by dangerous, drug-resistant bacteria that were extremely difficult to treat.
So you had patients who went to the hospital, often getting diagnostic or therapeutic procedures that they did not think would be a big deal, only to come out with infections that damaged organs, required months of intensive care, or, tragically, proved fatal.
Our lawyers are investigating Ozempic lawsuits for patients with NAION, gastroparesis, or gastrointestinal conditions, including bowel obstruction or cyclic vomiting syndrome.
Ozempic is the popular brand name for semaglutide, a prescription drug approved for the treatment of type 2 diabetes. As we all know, Ozempic is also commonly used as a weight management drug. Recent scientific studies have shown that taking Ozempic, particularly at higher doses, can cause gastroparesis.
Lawsuit Information Center